Literature DB >> 20515301

Insulin pump use in type 2 diabetes.

Bruce W Bode1.   

Abstract

Continuous subcutaneous insulin infusion (CSII) for type 2 diabetes mellitus (T2DM) is a promising therapy, but the clinical evidence supporting it is mixed. Large randomized controlled trials have concluded that CSII was equivalent to multiple daily injections (MDI), whereas smaller trials have concluded that CSII was superior. Simpler insulin regimens of CSII have been investigated for T2DM and may lead to improved outcomes. Future directions in this area include simpler insulin pumps and the use of concentrated insulins (U-500), neither of which has left the feasibility stage of research. CSII may be appropriate for some people with T2DM, especially those for whom MDI therapy has failed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20515301      PMCID： PMC2924784          DOI： 10.1089/dia.2009.0192

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


  19 in total

1.  Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

Authors:  E Berthe; B Lireux; C Coffin; B Goulet-Salmon; D Houlbert; S Boutreux; S Fradin; Y Reznik
Journal:  Horm Metab Res       Date:  2007-03       Impact factor: 2.936

2.  Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance.

Authors:  Wendy S Lane
Journal:  Endocr Pract       Date:  2006 May-Jun       Impact factor: 3.443

3.  Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.

Authors:  Steven V Edelman; Bruce W Bode; Timothy S Bailey; Mark S Kipnes; Rocco Brunelle; Xiaojing Chen; Juan P Frias
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

4.  A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Authors:  William H Herman; Liza L Ilag; Susan L Johnson; Catherine L Martin; Joyce Sinding; Abdulaziz Al Harthi; Cynthia D Plunkett; Frankie B LaPorte; Ray Burke; Morton B Brown; Jeffery B Halter; Philip Raskin
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

5.  Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes.

Authors:  F Labrousse-Lhermine; L Cazals; J-B Ruidavets; H Hanaire
Journal:  Diabetes Metab       Date:  2007-05-01       Impact factor: 6.041

6.  Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes.

Authors:  T Parkner; T Laursen; E T Vestergaard; H Hartvig; J S Smedegaard; T Lauritzen; J S Christiansen
Journal:  Diabet Med       Date:  2008-05       Impact factor: 4.359

7.  Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.

Authors:  K S Polonsky; B D Given; L J Hirsch; H Tillil; E T Shapiro; C Beebe; B H Frank; J A Galloway; E Van Cauter
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

8.  Three-year efficacy of complex insulin regimens in type 2 diabetes.

Authors:  Rury R Holman; Andrew J Farmer; Melanie J Davies; Jonathan C Levy; Julie L Darbyshire; Joanne F Keenan; Sanjoy K Paul
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

9.  Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes.

Authors:  Deepti G Bulchandani; Tara Konrady; Mitchell S Hamburg
Journal:  Endocr Pract       Date:  2007 Nov-Dec       Impact factor: 3.443

10.  Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.

Authors:  M Monami; C Lamanna; N Marchionni; E Mannucci
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-03-19       Impact factor: 2.949
View more
  11 in total

1.  A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.

Authors:  Juan P Frias; Bruce W Bode; Timothy S Bailey; Mark S Kipnes; Rocco Brunelle; Steven V Edelman
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

2.  Do perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.

Authors:  James J Chamberlain; Emily Gilgen
Journal:  J Diabetes Sci Technol       Date:  2014-09-30

3.  A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.

Authors:  Cari Berget; Laurel H Messer; Gregory P Forlenza
Journal:  Diabetes Spectr       Date:  2019-08

4.  Analysis of "Laboratory and Benchtop Performance of a Mealtime Insulin Delivery System".

Authors:  Eric Zijlstra
Journal:  J Diabetes Sci Technol       Date:  2018-04-05

5.  Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Control and Usability Study (ABACUS).

Authors:  Christopher G Parkin; Katharine Barnard; Deborah A Hinnen
Journal:  J Diabetes Sci Technol       Date:  2015-03-20

6.  High reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy.

Authors:  Katharine D Barnard; Michael Bromba; Mirja de Lange; Marine Halbron; Brian L Levy; Marc Lévy; Bernhard Lippmann-Grob; Kieran Walshe; Ralph Ziegler
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

Review 7.  Insulin therapy.

Authors:  Monika Lechleitner; Friedrich Hoppichler
Journal:  Wien Med Wochenschr       Date:  2011-05-23

8.  Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.

Authors:  Delin Ma; Cai Chen; Yu Lu; Jingdong Ma; Ping Yin; Junhui Xie; Yan Yang; Shiying Shao; Zhelong Liu; Xinrong Zhou; Gang Yuan; Xuefeng Yu
Journal:  Diabetes Technol Ther       Date:  2013-08-24       Impact factor: 6.118

Review 9.  Identifying and meeting the challenges of insulin therapy in type 2 diabetes.

Authors:  Christopher Sorli; Michael K Heile
Journal:  J Multidiscip Healthc       Date:  2014-07-02

Review 10.  Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.

Authors:  Paolo Pozzilli; Tadej Battelino; Thomas Danne; Roman Hovorka; Przemyslawa Jarosz-Chobot; Eric Renard
Journal:  Diabetes Metab Res Rev       Date:  2015-06-22       Impact factor: 4.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.